Replies to post #57503 on US Stem Cell Inc (USRM)

[Luho]

I'd say pretty strong chance based on 3 simple things:

A) Significantly positive results from phase 2 trial

B) RMAT is a real avenue being utilized now in health care

C) 100,000,000 dollars worth of R&D